Trial intelligence / Profile preview

Efficacy of thiotepa in hematopoietic stem cell transplantation for acute lymphoblastic leukemia

IRCT20140818018842N39Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of thiotepa in acute lymphoblastic leukemia (ALL), sponsored by Tehran University of Medical Sciences. Started Apr 2024; status: completed.

02

Drugs

thiotepa
03

Conditions

acute lymphoblastic leukemia (ALL)

Beyond the preview

Go deeper on IRCT20140818018842N39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20140818018842N39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call